Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 798.35 | 634.32 | 297.80 | ||
| High | 807.12 | 651.00 | 300.08 | ||
| Low | 796.70 | 633.60 | 292.10 | ||
| Latest | 802.54 | 644.23 | 292.96 | ||
| Change | +4.77 | +14.87 | -1.34 | ||
| % Change | +0.60% | +2.36% | -0.46% | ||
| Volume | 124,223 | 606,664 | 340,809 | ||
| 20-Day Average Volume | 323,549 | 966,209 | 1,049,519 | ||
| Previous Close | 797.77 | 629.36 | 294.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 793.76 | 705.91 | 297.63 | ||
| 20-Day Raw Stochastic | 52.40% | 22.58% | 27.86% | ||
| 20-Day Relative Strength | 52.17 | 34.89 | 43.43 | ||
| Weighted Alpha | +28.65 | +3.90 | -14.42 | ||
| Today's Opinion | 24% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 24% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 16% Buy | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.36% since 05/13/26 | -10.27% since 05/13/26 | +0.71% since 05/13/26 | ||
| Low | 775.62 on 05/19/26 | 610.60 on 05/18/26 | 284.38 on 05/19/26 | ||
| High | 827.95 on 05/14/26 | 722.51 on 05/14/26 | 300.08 on 05/20/26 | ||
| 1-Month | |||||
| %Chg | -4.15% since 04/20/26 | -13.80% since 04/20/26 | -5.59% since 04/20/26 | ||
| Low | 754.84 on 04/29/26 | 610.60 on 05/18/26 | 284.28 on 05/11/26 | ||
| High | 840.67 on 05/07/26 | 767.21 on 04/23/26 | 317.55 on 04/30/26 | ||
| 3-Month | |||||
| %Chg | -5.28% since 02/20/26 | -17.15% since 02/20/26 | -12.68% since 02/20/26 | ||
| Low | 661.85 on 03/20/26 | 610.60 on 05/18/26 | 284.28 on 05/11/26 | ||
| High | 852.28 on 04/17/26 | 794.77 on 03/03/26 | 343.36 on 04/14/26 | ||
| 6-Month | |||||
| %Chg | -12.92% since 11/20/25 | -12.35% since 11/20/25 | -34.15% since 11/20/25 | ||
| Low | 661.85 on 03/20/26 | 610.60 on 05/18/26 | 284.28 on 05/11/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 479.79 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 49,368,396 | 66,635,316 | 39,292,876 | ||
| Shares Outstanding, K | 61,883 | 105,720 | 133,513 | ||
| Annual Sales | 4,248,050,000 | 14,342,900,000 | 3,713,940,000 | ||
| Annual Net Income | 1,292,040,000 | 4,504,900,000 | 313,750,000 | ||
| Last Quarter Sales | 1,313,000,000 | 3,605,400,000 | 1,167,180,000 | ||
| Last Quarter Net Income | 366,000,000 | 727,200,000 | 205,990,000 | ||
| 60-Month Beta | 0.46 | 0.30 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.52 on 05/07/26 | 9.47 on 04/29/26 | 1.99 on 04/30/26 | ||
| Earnings Date | 07/30/26 | 08/07/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | 0.940 on 05/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 05/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 34.56 | 16.95 | 78.43 | ||